share_capital · exchange · ESPI
Invitation and materials for a General shareholders meeting
This is a Warsaw Filings record of a company notice from the Warsaw Stock Exchange and the Polish court register. It states what was filed, by whom, and when.
SOPHARMA AD published a share capital on 2026-09-25 14:17:57 CEST.
- Legal basis
- Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
Company:
SOPHARMA AD
Official name: SOPHARMA AD
No Polish KRS
LEI 097900BGGW0000048796
MIC XWAR
This issuer does not have a Polish court-register number. The ticker and LEI come from the exchange notice. This page is not a court record.
Attachments named in the source
The JSON path needs header X-API-Key, except the public sample at /api/v1/sample.
Original source text
UNI-EN: Invitation and materials for a General shareholders meeting Data: 2026-09-25 Firma: SOPHARMA AD Spis tresci: 1. REPORT 2. ESAP METADATE 3. INFORMATION ABOUT THE ENTITY 4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY Spis zalacznikow: SFA_286_EGM_30102026.rar Arkusz: REPORT Znaleziono 1 załącznik Nazwa arkusza: REPORT POLISH FINANCIAL SUPERVISION AUTHORITY UNI - EN REPORT No 286 / 2026 Date of issue: 2026-09-25 Short name of the issuer SOPHARMA AD Subject Invitation and materials for a General shareholders meeting Official market - legal basis Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe Unofficial market - legal basis Contents of the report: Publication of materials for holding an Extraordinary General Meeting of Shareholders of "Sopharma" AD, scheduled for October 30, 2026 and in the absence of a quorum on this date - for November 20, 2026 Sofia, Bulgaria, September 25, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of "Sopharma" AD _SFA: "BSE" AD, SPH: Warsaw Stock Exchange_ presents the following materials on the agenda of EGM convened for October 30, 2026 and in the absence of a quorum on this date - for November 20, 2026, to the attention of shareholders, which will be available on the website of Extri News _www.x3news.com_, in the FSC system, on the Company's website https://www.sopharmagroup.com/bg/investitori/korporativni-sabitia/obshto-sabranie-na-aktsionerite and on the website www.investor.bg, as well as in hard copy at the address of the Company: 1. Minutes of a meeting of the Board of Directors for convening an Extraordinary Meeting of Shareholders of "Sopharma" AD; 2. Invitation to convene the Extraordinary General Meeting of Shareholders _EGM_ of "Sopharma" AD; 3. Power of attorney - an example for representing a shareholder at the EGM; 4. Declaration for voting by correspondence - an example for the EGM; 5. For item 1 of the agenda: Approval of the 6-month financial report for the first half of 2026- is already available on the website of Extri News _www.x3news.bg_, in the FSC system, on the company's website and on the website www.investor.bg; 6. For item 2 of the agenda: Approval of a decision under Article 30, paragraphs 5-7 of the Company's Articles of Association for the distribution of profit and payment of an interim dividend based on the adopted 6-month financial report; 7. For item 3 of the agenda: Election of a registered auditor to perform a mandatory assurance engagement regarding the sustainability of the consolidated sustainability report of "Sopharma" AD for 2026, if applicable. Annexes File Description SFA_286_EGM_30102026.rar Invitation and materials for a General shareholders meeting Nazwa arkusza: ESAP METADATE Legal framework Type of information TRANSD Additional regulated information required to be disclosed under the laws of a Member State RegulatoryData Collection Body PLKNF Unique data record identifier Type of submission New _to be used for new information_ Voluntary information flag Date or period covered [Date or beginning of the period to which the information relates] 2026-10-30 Date or period covered [Date or end of the period to which the information relates] 2026-10-30 Personal data flag Macierzyste państwo członkowskie, w stosownych przypadkach PL DocumentReference Język, w którym przekazano informacje Oryginał _ORIG_ czy tłumaczenie _TRAN_ Numer referencyjny pliku danych PL ORIG SubmittingEntity Submitting entity LEI or Submitting entity name - natural person 097900BGGW0000048796 RelatedEntity/LegalPerson Entity LEI Size of the entity Industry sector_s_ 097900BGGW0000048796 Large undertaking _acc. NACE_: C Nazwa arkusza: INFORMATION ABOUT THE ENTITY SOPHARMA AD _fullname of the issuer_ SOPHARMA AD Farmaceutyczny _far_ _short name of the issuer_ _sector according to clasification of the WSE in Warsow_ 1220 Sofia _post code_ _city_ IlienskoShosse 16 _street_ _number_ +359 2 813 42 00 +359 2 936 02 86 _phone number_ _fax_ _e-mail_ _web site_ nd _NIP_ _REGON_ Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY SIGNATURE OF PERSONS REPRESENTING THE COMPANY Date Name Position / Function Signature 2026-09-25 Ognian Ivanov Donev Executive Director Identyfikator raportu jjvuszwyf1 Nazwa raportu UNI-EN Symbol raportu UNI-EN Nazwa emitenta SOPHARMA AD Symbol Emitenta SOPHARMA AD Tytul Invitation and materials for a General shareholders meeting Sektor Farmaceutyczny (far) Kod 1220 Miasto Sofia Ulica IlienskoShosse Nr 16 Tel. +359 2 813 42 00 Fax +359 2 936 02 86 e-mail NIP nd REGON Data sporzadzenia 2026-09-25 Rok biezacy 2026 Numer 286 adres www Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.